BSEQ1 FY25

BSE Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,046P/E: 46.0Market Cap: ₹1.3L CrSector: Capital Markets

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • BSE recorded record quarterly revenues of INR 674.4 crores, up 149% YoY; operational revenues rose 182% to INR 607.7 crores, indicating robust growth momentum.
  • Strong contribution from all business lines and product improvements boost confidence in sustained revenue growth.
  • Sensex and Bankex derivatives markets have shown record trading volumes and premium turnover, reflecting increasing market participation.
  • The surge in retail and institutional participation, with registered investors growing 51% to 18.4 crore, underpins volume growth potential.
  • Launch of single stock derivatives with mid-month expiry exceeded expectations, signaling opportunity for segment expansion.
  • Emerging regulatory changes (e.g., weekly expiry contracts) introduce uncertainties but also open new growth avenues.
  • BSE remains committed to providing a vibrant platform and adapting proactively to regulatory and market dynamics to sustain growth in sales, revenues, and volumes.

See what BSE management said on margin guidance — free account, 30 seconds.

Fundraise plans

The document does not explicitly mention any current or future plans for fundraising through debt or equity. Key points related to financial position and growth initiatives include: - BSE reported record quarterly revenues and strong profit growth in Q1 FY '25. - The company is focused on expanding its business lines, such as mutual fund distribution (StAR MF 2.0) and index business via its subsidiary AIPL. - There is ongoing engagement with regulatory changes impacting transaction charges and market structure. - No specific mentions were made about raising funds through debt or equity during this period. - The management emphasized strategizing around emerging regulatory requirements and market opportunities rather than fundraising plans. In summary, based on available information on these pages, there is no indication of imminent or planned fundraising via debt or equity.

See what BSE management said on order book — free account, 30 seconds.

Capex plans

Yes
- BSE is making significant enhancements to its mutual fund platform, BSE StAR MF, with the revamped version 2.0 approaching launch, focusing on scalability, functionality, and order processing improvements. - Continued investments are being made in BSE StAR MF to support growth and improve the platform. - BSE has completed the acquisition of S&P Dow Jones Indices' entire equity stake in Asia Index Private Limited, making it a wholly owned subsidiary, committed to improving and expanding its index business. - Ongoing technology investments are supporting growth across BSE’s businesses while improving efficiency and profitability margins. - The company is working on redesigning existing charge structures for equity derivatives segment in line with regulatory requirements, which may also involve strategic adjustments. No explicit mention of other large capital expenditure or strategic investments beyond these were noted in the provided pages.

Track BSE — get its next earnings analysis in your feed

How does BSE rank vs peers in Capital Markets?

Pro feature
ThisBSE
Rev 2Mar 3

How does BSE rank in Capital Markets?

Compare BSE against every Capital Markets company (Q1 FY25) on revenue, margins and earnings-call signals.

View Capital Markets leaderboard →

Others in Capital Markets this season

  • CARE Ratings Ltd (Q1 FY25)

    78.92 Crs, up 19% YoY (Page 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

  • ICRA Ltd (Q3 FY25)

    Q3 FY2025 Revenue: ₹120.9 crore, up 5.5% YoY from ₹114.6 crore in Q3 FY2024 (Page 6). Key concall takeaways from ICRA Ltd's Q3 FY25 earnings call — and how it…

  • CARE Ratings Ltd (Q3 FY26)

    90.24 Crs, up 15% YoY (Page 12, 2) . Key concall takeaways from CARE Ratings Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.

  • CARE Ratings Ltd (Q1 FY27)

    111.68 Cr, up 18.9% YoY (Page 2, 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →